Stay updated on Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record for rucaparib plus nivolumab in advanced or metastatic biliary tract cancer, including its design, eligibility criteria, locations, outcomes, and supporting documents. The record also includes publication and individual participant data-sharing information.
    Difference
    53%
    Check dated 2026-11-08T13:59:48.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:26:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in NIH content.
    Difference
    1%
    Check dated 2026-10-25T15:55:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T21:00:27.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.0 to v3.7.1; the 403 error page otherwise remains unchanged.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:39.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now loads a 403 Forbidden error page, replacing the usual study content with a standard error screen. This blocks access to the study record while retaining the site chrome (header/footer).
    Difference
    19%
    Check dated 2026-09-20T20:39:31.000Z thumbnail image

Stay in the know with updates to Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib + Nivolumab in Advanced Biliary Tract Cancer Clinical Trial page.